About seller
This review focuses on the role of the NLRP3 inflammasome in the pathophysiology of PE. Copyright © 2020 Shirasuna, Karasawa and Takahashi.Objective Automated seizure detection is a key aspect of wearable seizure warning systems. As a result, the quality of life of refractory epilepsy patients could be improved. Most state-of-the-art algorithms for heart rate-based seizure detection use a so-called patient-independent approach, which do not take into account patient-specific data during algorithm training. Although such systems are easy to use in practice, they lead to many false detections as the ictal heart rate changes are patient-dependent. In practice, only a limited amount of accurately annotated patient data is typically available, which makes it difficult to create fully patient-specific algorithms. Methods In this context, this study proposes for the first time a new transfer learning approach that allows to personalize heart rate-based seizure detection by using only a couple of days of data per patient. The algorithm was evaluated on 2,172 h of single-lead ECG data from 24 temporal lobe epilepsy patients including 227 focal impaired awareness seizures. Results The proposed personalized approach resulted in an overall sensitivity of 71% with 1.9 false detections per hour. This is an average decrease in false detection rate of 37% compared to the reference patient-independent algorithm using only a limited amount of personal seizure data. The proposed transfer learning approach adapts faster and more robustly to patient-specific characteristics than other alternatives for personalization in the literature. Conclusion The proposed method allows an easy implementable solution to personalize heart rate-based seizure detection, which can improve the quality of life of refractory epilepsy patients when used as part of a multimodal seizure detection system. Copyright © 2020 De Cooman, Vandecasteele, Varon, Hunyadi, Cleeren, Van Paesschen and Van Huffel.Manganese-enhanced magnetic resonance imaging (MEMRI) relies on the strong paramagnetism of Mn2+. Mn2+ is a calcium ion analog and can enter excitable cells through voltage-gated calcium channels. Mn2+ can be transported along the axons of neurons via microtubule-based fast axonal transport. Based on these properties, MEMRI is used to describe neuroanatomical structures, monitor neural activity, and evaluate axonal transport rates. The application of MEMRI in preclinical animal models of central nervous system (CNS) diseases can provide more information for the study of disease mechanisms. In this article, we provide a brief review of MEMRI use in CNS diseases ranging from neurodegenerative diseases to brain injury and spinal cord injury. Copyright © 2020 Yang and Li.Introduction Deep brain stimulation (DBS) is an effective therapy for resting tremor in Parkinson's disease (PD). However, quick and objective biomarkers for quantifying the efficacy of DBS intraoperatively are lacking. Therefore, we aimed to study how DBS modulates the intraoperative neuromuscular pattern of resting tremor in PD patients and to find predictive surface electromyography (sEMG) biomarkers for quantifying the intraoperative efficacy of DBS. Methods Intraoperative sEMG of 39 PD patients with resting tremor was measured with the DBS on and off, respectively, during the intraoperative DBS testing stage. Twelve signal features (time and frequency domains) were extracted from the intraoperative sEMG data. These sEMG features were associated with the clinical outcome to evaluate the efficacy of intraoperative DBS. Also, an sEMG-based prediction model was established to predict the clinical improvement rate (IR) of resting tremor with DBS therapy. Results A typical resting tremor with a peak frequency odifying the frequency pattern. Three features showed strong robustness and could be used as quick intraoperative biomarkers to quantify and predict the efficacy of DBS in PD patients with resting tremor. Copyright © 2020 Wang, Burns, Xu, Hu, Fan, Han, Wang, Michitomo, Xia, Zhang, Wang and Meng.Spinal muscular atrophy (SMA) is a severe neuromuscular disorder characterized by the degeneration of motor neurons in the spinal cord, and comprises a broad clinical spectrum. With the advent of new therapies (e.g., Nusinersen) for patients of all ages and disease stages, sensitive clinical measures are needed to detect slight changes in muscle force even in immobilized, severely affected patients often unable to move limbs. As for these patients, well-established outcome scales set out to evaluate motor function do not work properly, we propose measurement of maximum bite force which is able to detect subtle changes of bulbar function. Requirements for this approach are mentioned, challenges are discussed, and first insights from a pilot study are presented. Finally, a study design is proposed to evaluate the measurement of maximum bite force during the follow up of SMA patients with and without a disease modifying therapy. VTP50469 mw Copyright © 2020 Kruse, Lehmann, Braumann, Fink and Wunderlich.Background and Aim Gut bacteria play an important role in the pathogenesis of Parkinson's disease (PD). However, the alteration of fecal microbiota in PD with cognitive impairment remains unexplored. This study aimed to explore whether the gut microbiota of patients with PD having mild cognitive impairment (PD-MCI) were different from those with PD having normal cognition (PD-NC) and from healthy controls (HC). Also, the study probed the association between altered gut microbiota and cognitive ability in patients with PD. Methods The fecal bacteria composition and short-chain fatty acids of 13 patients with PD-MCI, 14 patients with PD-NC, and 13 healthy spouses were analyzed using 16S ribosomal RNA sequencing and gas chromatography-mass spectrometry. Results Compared with HC, the fecal microbial diversities increased in patients with PD-MCI and PD-NC. After adjusting the influence of age, sex, body mass index, education, and constipation using the statistical method, the relative abundances of two families (Rikenellaceae and Ruminococcaceae) and four genera (Alistipes, Barnesiella, Butyricimonas, and Odoribacter) were found to be higher in the feces of the PD-MCI group compared with the other two groups. Moreover, the abundance of genus Blautia and Ruminococcus decreased obviously in the PD-MCI group compared with the PD-NC group. Further, the abundance of genera Butyricimonas, Barnesiella, Alistipes, Odoribacter, and Ruminococcus negatively correlated with cognition ability. Conclusion Compared with HC and patients with PD-NC, the gut microbiota of patients with PD-MCI was significantly altered, particularly manifesting in enriched genera from Porphyromonadaceae family and decreased the abundance of genera Blautia and Ruminococcus. Copyright © 2020 Ren, Gao, Qiu, Jiang, Zhang, Zhang, Wang, Zhang, Wang and Nie.